CL

Crédit Lyonnais Private Equity

Europe, Ile-de-France, France, Paris

Description

Crédit Lyonnais Private Equity offers investment to a diverse range of companies in France.

Investor Profile

Crédit Lyonnais Private Equity has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (44%)
  • Series Unknown (33%)
  • Series C (22%)

Country Focus

  • Sweden (33%)
  • France (22%)
  • United States (22%)
  • Switzerland (11%)
  • United Kingdom (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Pharmaceutical
  • Mobile
  • Wireless
  • Biopharma
  • Medical
  • Life Science
  • Embedded Systems
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Crédit Lyonnais Private Equity frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 2
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 2
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Rothschild & Co.
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Global Life Science Ventures
Europe, Bayern, Germany, München
Co-Investments: 1
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4

What are some of recent deals done by Crédit Lyonnais Private Equity?

Biolipox

Solna, Stockholms Lan, Sweden

Biolipox is a research-intense pharmaceutical company that develops new treatments for inflammatory diseases

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series CJan 12, 2005
Amount Raised: $41,000,000
Emulation and Verification Engineering

San Jose, California, United States

Emulation and Verification Engineering develops hardware and software co-verification solutions for microelectronics companies.

ElectronicsEnterprise SoftwareHardwareSoftware
Series UnknownJun 24, 2004
Amount Raised: $7,200,000
CareX SA

Illkirch, Alsace, France

CareX SA is a biopharmaceutical company focused on metabolic disease.

BiotechnologyHealth CareLife Science
Series BMar 8, 2004
Amount Raised: $32,000,000
DiBcom

Palaiseau, Ile-de-France, France

DiBcom, a fabless semiconductor company offering integrated circuits, is specialized in the development of broadband wireless solutions.

Developer PlatformSemiconductorWireless
Series UnknownDec 31, 2003
Amount Raised: $13,300,000
Esmertec

Dubendorf, Zurich, Switzerland

Esmertec AG a Zurich, Switzerland-based provider of Java solutions for mobile multimedia phones and embedded devices.

Embedded SystemsMobileSoftwareWeb Development
Series CNov 13, 2003
Amount Raised: $26,946,346
Orexo

Uppsala, Uppsala Lan, Sweden

Orexo is a pharmaceutical company developing improved treatments using proprietary drug delivery technology.

BiotechnologyHealth CarePharmaceutical
Series BJan 17, 2003
Amount Raised: $22,380,925
Biolipox

Solna, Stockholms Lan, Sweden

Biolipox is a research-intense pharmaceutical company that develops new treatments for inflammatory diseases

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJan 15, 2003
Amount Raised: $21,000,000
Envivio

San Francisco, California, United States

Envivio provides software-based solutions for multi-screen video processing and delivery.

BroadcastingSoftwareTelecommunications
Series BMay 22, 2002
Amount Raised: $14,000,000
Bango

Cambridge, Cambridgeshire, United Kingdom

Bango is the standard platform chosen by leading global stores to deliver mobile payments to everyone.

MobileMobile PaymentsWireless
Series UnknownApr 12, 2002
Amount Raised: $2,462,489